Biohaven Statistics
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.93+0.05 (+0.42%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 11.89 -0.34%
Biohaven by the numbers
Biohaven has a market capitalization of $1.80 billion based on 151.04M shares outstanding. With trailing EPS of $-4.56, Biohaven is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.5% below its 50-day average and 1.1% below its 200-day average.
Average daily trading volume is 2.62M shares, or about $31.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BHVN valuation vs. peer median
| Metric | BHVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.80B | $1.82B | -1% |
| Avg. volume | 2.62M | 1.18M | +122% |
Peer median across 8 companies: GENB, URGN, ZYME, XNCR, TRVI, GPCR, NUVB, XERS.
Valuation
- Market cap
- $1.80B
- EPS (TTM)
- $-4.56
- Shares outstanding
- 151.04M
Price and trading
- Previous close
- 11.88
- Open
- 11.83
- Day range
- 11.46 – 12.12
- 52-week range
- 7.48 – 18.57
- 52-week change
- -22.23%
- Beta
- —
- Volume
- 2.70M
- Average volume
- 2.62M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.80B
- Forward Pe
- -6.37
- Eps
- -4.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.57
- Week52 Low
- 7.48
- Avg Volume
- 2.62M
- Shares Outstanding
- 151.04M
- Ma50
- 13.96
- Ma200
- 12.07
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -35.74%
- Pct From52w Low
- 59.49%